MENU

RLMD Relmada Therapeutics Chart, History Price & Graph

a clinical-stage biotechnology company, which engages in the development of d-methadone receptor antagonist, which is a chemical entity that addresses areas of high unmet medical need in the treatment of central nervous system diseases

RLMD
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
View a ticker or compare two or three
RLMD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

RLMD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RLMD has been loosely correlated with XENE. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if RLMD jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLMD
1D Price
Change %
RLMD100%
+11.06%
XENE - RLMD
55%
Loosely correlated
-0.26%
RNAC - RLMD
38%
Loosely correlated
-2.85%
SYRE - RLMD
36%
Loosely correlated
+2.13%
GRDX - RLMD
36%
Loosely correlated
-3.70%
BCYC - RLMD
35%
Loosely correlated
+0.78%
More
Relmada Therapeutics (RLMD) Stocks Price History Chart, Support & Resistance Graph - Tickeron.com